Pain medicine

Another painful day in the bio-trading world. To hopefully ease some of the ache I have started a position in ZLCS ahead of phase 2 data for their analgesic development compound, Z160. Volume has been growing since the start of the month, with a favourable article in Seeking Alpha having been published on August 1. Hopefully interest will grow as the data draws near (expected early in Q4). I am in at $0.71.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s